{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T17:10:06Z","timestamp":1780765806539,"version":"3.54.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["11631014"],"award-info":[{"award-number":["11631014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61972399"],"award-info":[{"award-number":["61972399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Synergistic drug combinations can improve the therapeutic effect and reduce the drug dosage to avoid toxicity. In previous years, an in vitro approach was utilized to screen synergistic drug combinations. However, the in vitro method is time-consuming and expensive. With the rapid growth of high-throughput data, computational methods are becoming efficient tools to predict potential synergistic drug combinations. Considering the limitations of the previous computational methods, we developed a new model named Siamese Network and Random Matrix Projection for AntiCancer Drug Combination prediction (SNRMPACDC). Firstly, the Siamese convolutional network and random matrix projection were used to process the features of the two drugs into drug combination features. Then, the features of the cancer cell line were processed through the convolutional network. Finally, the processed features were integrated and input into the multi-layer perceptron network to get the predicted score. Compared with the traditional method of splicing drug features into drug combination features, SNRMPACDC improved the interpretability of drug combination features to a certain extent. In addition, the introduction of convolutional networks can better extract the potential information in the features. SNRMPACDC achieved the root mean-squared error of 15.01 and the Pearson correlation coefficient of 0.75 in 5-fold cross-validation of regression prediction for response data. In addition, SNRMPACDC achieved the AUC of 0.91\u2009\u00b1\u20090.03 and the AUPR of 0.62\u2009\u00b1\u20090.05 in 5-fold cross-validation of classification prediction of synergistic or not. These results are almost better than all the previous models. SNRMPACDC would be an effective approach to infer potential anticancer synergistic drug combinations.<\/jats:p>","DOI":"10.1093\/bib\/bbac503","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T04:40:56Z","timestamp":1669264856000},"source":"Crossref","is-referenced-by-count":63,"title":["SNRMPACDC: computational model focused on Siamese network and random matrix projection for anticancer synergistic drug combination prediction"],"prefix":"10.1093","volume":"24","author":[{"given":"Tian-Hao","family":"Li","sequence":"first","affiliation":[{"name":"School of Information and Control Engineering, China University of Mining and Technology , Xuzhou, 221116 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-4007","authenticated-orcid":false,"given":"Chun-Chun","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Information and Control Engineering, China University of Mining and Technology , Xuzhou, 221116 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Information and Control Engineering, China University of Mining and Technology , Xuzhou, 221116 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9028-5342","authenticated-orcid":false,"given":"Xing","family":"Chen","sequence":"additional","affiliation":[{"name":"Artificial Intelligence Research Institute, China University of Mining and Technology , Xuzhou, 221116 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"2023011917142943900_ref1","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","article-title":"An expanded view of complex traits: from polygenic to omnigenic","volume":"169","author":"Boyle","year":"2017","journal-title":"Cell"},{"key":"2023011917142943900_ref2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Drazen","year":"2017","journal-title":"N Engl J Med"},{"key":"2023011917142943900_ref3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","article-title":"Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review","volume":"138","author":"Csermely","year":"2013","journal-title":"Pharmacol Ther"},{"key":"2023011917142943900_ref4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"2023011917142943900_ref5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"2023011917142943900_ref6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3892\/or.2016.5315","article-title":"Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression","volume":"37","author":"Huang","year":"2017","journal-title":"Oncol Rep"},{"key":"2023011917142943900_ref7","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1158\/0008-5472.CAN-06-4495","article-title":"Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification","volume":"67","author":"Tooker","year":"2007","journal-title":"Cancer Res"},{"key":"2023011917142943900_ref8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2023011917142943900_ref9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nrd2424","article-title":"The design of drugs for HIV and HCV","volume":"6","author":"De Clercq","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"2023011917142943900_ref10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004975","article-title":"NLLSS: predicting synergistic drug combinations based on semi-supervised learning","volume":"12","author":"Chen","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"2023011917142943900_ref11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1200\/JCO.2008.19.8135","article-title":"A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer","volume":"27","author":"Hecht","year":"2009","journal-title":"J Clin Oncol"},{"key":"2023011917142943900_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Therap"},{"key":"2023011917142943900_ref13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N Engl J Med"},{"key":"2023011917142943900_ref14","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1","volume":"285","author":"Mandelbrot","year":"2001","journal-title":"JAMA"},{"key":"2023011917142943900_ref15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1008342013224","article-title":"Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma","volume":"11","author":"Roth","year":"2017","journal-title":"Ann Oncol"},{"key":"2023011917142943900_ref16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drudis.2015.09.003","article-title":"Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives","volume":"21","author":"Bulusu","year":"2016","journal-title":"Drug Discov Today"},{"key":"2023011917142943900_ref17","doi-asserted-by":"crossref","first-page":"bbab355","DOI":"10.1093\/bib\/bbab355","article-title":"Machine learning methods, databases and tools for drug combination prediction","volume":"23","author":"Wu","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023011917142943900_ref18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bib\/bbw104","article-title":"Predictive approaches for drug combination discovery in cancer","volume":"19","author":"Madani Tonekaboni","year":"2018","journal-title":"Brief Bioinform"},{"key":"2023011917142943900_ref19","first-page":"1","article-title":"In-silico prediction of synergistic anti-cancer drug combinations using multi-omics data","volume-title":"Sci Rep","author":"Celebi","year":"2019"},{"key":"2023011917142943900_ref20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005308","article-title":"A computational approach for identifying synergistic drug combinations","volume":"13","author":"Gayvert","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"2023011917142943900_ref21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006752","article-title":"Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer","volume":"15","author":"Malyutina","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"2023011917142943900_ref22","first-page":"1","article-title":"Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets","volume-title":"BMC Bioinform","author":"Amzallag","year":"2019"},{"key":"2023011917142943900_ref23","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with Deep Learning","volume":"34","author":"Preuer","year":"2017","journal-title":"Bioinformatics"},{"key":"2023011917142943900_ref24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"key":"2023011917142943900_ref25","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1109\/JBHI.2018.2852274","article-title":"Ensemble prediction of synergistic drug combinations incorporating biological, chemical, pharmacological, and network knowledge","volume":"23","author":"Ding","year":"2019","journal-title":"IEEE J Biomed Health Inform"},{"key":"2023011917142943900_ref26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fgene.2019.00600","article-title":"Five-feature model for developing the classifier for synergistic vs. antagonistic drug combinations built by XGBoost","volume":"10","author":"Ji","year":"2019","journal-title":"Front Genet"},{"key":"2023011917142943900_ref27","first-page":"67","article-title":"Synergistic drug combinations prediction by integrating pharmacological data","volume-title":"Synth Syst Biotechnol","author":"Zhang","year":"2019"},{"key":"2023011917142943900_ref28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41576-019-0122-6","article-title":"Deep learning: new computational modelling techniques for genomics","volume":"20","author":"Eraslan","year":"2019","journal-title":"Nat Rev Genet"},{"key":"2023011917142943900_ref29","first-page":"768","article-title":"Regularization and variable selection via the elastic net","volume-title":"J R Stat Soc Series B Stat Methodol J R STAT SOC B","author":"Hui","year":"2005"},{"key":"2023011917142943900_ref30","first-page":"S69","article-title":"DeepTox: toxicity prediction using deep learning","volume-title":"Front Environ Sci","author":"Klambauer","year":"2017"},{"key":"2023011917142943900_ref31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"2023011917142943900_ref32","first-page":"1189","article-title":"Greedy function approximation: a gradient boosting machine","volume-title":"Ann. Stat.","author":"JHJAoS","year":"2001"},{"key":"2023011917142943900_ref33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O'Neil","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2023011917142943900_ref34","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"2023011917142943900_ref35","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nbt.2391","article-title":"Systematic identification of synergistic drug pairs targeting HIV","volume":"30","author":"Tan","year":"2012","journal-title":"Nat Biotechnol"},{"key":"2023011917142943900_ref36","first-page":"585","article-title":"The toxicity of poisons applied jointly","volume-title":"Ann. Appl. Biol.","author":"Bliss","year":"1939"},{"key":"2023011917142943900_ref37","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"2023011917142943900_ref38","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"key":"2023011917142943900_ref39","first-page":"1","article-title":"jCompoundMapper: an open source Java library and command-line tool for chemical fingerprints","volume-title":"Journal of cheminformatics","author":"Hinselmann","year":"2011"},{"key":"2023011917142943900_ref40","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/bioinformatics\/btt105","article-title":"ChemoPy: freely available python package for computational biology and chemoinformatics","volume":"29","author":"Cao","year":"2013","journal-title":"Bioinformatics"},{"key":"2023011917142943900_ref41","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00204-015-1587-5","article-title":"Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations","volume":"90","author":"Singh","year":"2016","journal-title":"Arch Toxicol"},{"key":"2023011917142943900_ref42","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A landscape of pharmacogenomic interactions in cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"2023011917142943900_ref43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/bioinformatics\/btl033","article-title":"A new summarization method for Affymetrix probe level data","volume":"22","author":"Hochreiter","year":"2006","journal-title":"Bioinformatics"},{"key":"2023011917142943900_ref44","article-title":"Signature verification using a \"siamese\" time delay neural network","volume":"6","author":"Bromley","year":"1993","journal-title":"Adv Neural Inf Process Syst"},{"key":"2023011917142943900_ref45","first-page":"4353","article-title":"Learning to compare image patches via convolutional neural networks","author":"Zagoruyko","year":"2015","journal-title":"Proceedings of the IEEE conference on computer vision and pattern recognition"},{"key":"2023011917142943900_ref46","first-page":"5764","article-title":"Inverse discriminative networks for handwritten signature verification","author":"Wei","year":"2019","journal-title":"Proceedings of the IEEE\/CVF Conference on Computer Vision and Pattern Recognition (CVPR)"},{"key":"2023011917142943900_ref47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1142\/S0218001493000339","article-title":"Signature verification using a \u201csiamese\u201d time delay neural network","volume":"7","author":"Bromley","year":"1993","journal-title":"Int J Pattern Recogn Artif Intell"},{"key":"2023011917142943900_ref48","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1093\/bioinformatics\/btz411","article-title":"ReSimNet: drug response similarity prediction using Siamese neural networks","volume":"35","author":"Jeon","year":"2019","journal-title":"Bioinformatics"},{"key":"2023011917142943900_ref49","doi-asserted-by":"crossref","first-page":"bbab534","DOI":"10.1093\/bib\/bbab534","article-title":"SRDFM: Siamese Response Deep Factorization Machine to improve anti-cancer drug recommendation","volume":"23","author":"Su","year":"2022","journal-title":"Brief Bioinform"},{"key":"2023011917142943900_ref50","doi-asserted-by":"crossref","first-page":"i802","DOI":"10.1093\/bioinformatics\/bty573","article-title":"Predicting protein\u2013protein interactions through sequence-based deep learning","volume":"34","author":"Hashemifar","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/1\/bbac503\/48783094\/bbac503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/24\/1\/bbac503\/48783094\/bbac503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T17:48:27Z","timestamp":1674150507000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbac503\/6843566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,19]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbac503","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1]]},"published":{"date-parts":[[2022,11,23]]},"article-number":"bbac503"}}